Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia

Clinical trial NCT04657094 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04657094
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autoimmune Hemolytic Anemia Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Warm Antibody Autoimmune Hemolytic Anemia

Start date: 2021-03-16
Primary completion: 2023-04-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.